Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Julphar
Mallinckrodt
Chinese Patent Office
Merck
Chubb
Accenture
Dow

Generated: January 18, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: CEFOXITIN SODIUM

« Back to Dashboard

CEFOXITIN SODIUM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414 ANDA Sagent Pharmaceuticals 25021-109-10 10 VIAL in 1 CARTON (25021-109-10) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414 ANDA Sagent Pharmaceuticals 25021-110-20 10 VIAL in 1 CARTON (25021-110-20) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414 ANDA WG Critical Care, LLC 44567-245-25 25 VIAL in 1 CARTON (44567-245-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414 ANDA WG Critical Care, LLC 44567-245-85 25 VIAL in 1 CARTON (44567-245-85) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414 ANDA WG Critical Care, LLC 44567-246-25 25 VIAL in 1 CARTON (44567-246-25) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Acs Dobfar CEFOXITIN cefoxitin sodium INJECTABLE;INJECTION 065414 ANDA WG Critical Care, LLC 44567-246-85 25 VIAL in 1 CARTON (44567-246-85) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Chubb
UBS
Cipla
Medtronic
QuintilesIMS
Teva
Merck
Chinese Patent Office